Skip to content

Spotlight on Uncontrolled Hypertension: Assessing the Shift Towards Personalised Medicine – Part 2 | Post Assessment Survey

Thank you for watching 'Spotlight on Uncontrolled Hypertension: Assessing the Shift Towards Personalised Medicine – Part 2'. We’d like to ask a few short questions to gauge the impact of this activity.

If you wish to watch again or share with colleagues, you can watch, here.

This programme is supported by an unrestricted educational grant from AstraZeneca.
1.Did this activity improve your working knowledge on this topic/area?
2.Will you change or adapt your practice as a result of taking part in this activity?
3.Following the content of this peer-to-peer, are you more likely to test for elevated aldosterone in your patients with difficult to control hypertension?
4.Has this activity improved your knowledge on the role of aldosterone in the pathophysiology of hypertension?
5.Has this activity improved your familiarity with ongoing clinical trials of aldosterone synthase inhibitors (ASIs)?
6.Has this activity improved your familiarity with the mechanism of action of the ASIs?